News Verification

Piramal Pharma Limited received a query from the Stock Exchanges regarding a news article about a 10% surge in its share price. The company clarified that the news article does not contain any material information requiring disclosure under Regulation 30 of SEBI Listing Regulations. It further stated that all necessary information is already in the public domain and that the share price movement appears to be driven by market dynamics, with no specific undisclosed reason known to the company.